Study on drug characteristics of NCCN and CSCO clinical practice guidelines for high-prevalence tumors in ChinaZHANG Song-lin, AI Dan-dan, ZHANG Ran, CHANG Feng2447-2452
Cluster analysis of the current status and research hotspots of non-Hodgkin's lymphoma based on PubMed databaseZHANG Ya-ni, WU Fen, WANG Shu-min, LIU Chao, YANG Hao, ZHOU Jian-ping, ZHANG Li-tao2453-2460
Economic operation of Chinese pharmaceutical industry in the first quarter of 2019GUO Wen, ZHONG Yi-ming, ZHOU Bin2461-2467
Considerations on the design and implementation of chemical drugs stress testingGUO Di-liang2468-2472
Common problems analyses in the quality control and in vitro evaluation on consistency evaluation of oral solid dosage formsSHI Jing, XU Zhen-yu2473-2477
Determination of the contents of N-nitrosodimethylamine in valsartan by GC-MSWU Zhao-wei, DU Kai, WANG Lin, ZHENG Jie, HU Qin, ZHANG Zhe, WU Bin2478-2481
The proficiency testing for determination of osmolality of recombinant protein injectionQIN Xi, DING You-xue, ZHANG He-zhan, ZHAO Meng, LIU Lan, SHI Xin-chang, RAO Chun-ming2482-2485
Progress in clinical research on cabozantinib in the treatment of malignant tumorsWANG Long, ZHANG Li, WANG Juan, GE Chao-liang2486-2491